Access cutting-edge prediabetes treatment through this clinical trial at a research site in Sommerville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Sommerville location
Preparing your pre-screening questions…
Access prediabetes specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prediabetes treatment provided free
Check if you qualify for this prediabetes clinical trial in Sommerville, MA
No-Cost Study Care
Local to Sommerville
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This pilot study aims to explore the potential benefits of consuming Greek bottarga (grey mullet fish roe) in individuals with at least one metabolic abnormality (low HDL cholesterol, high LDL cholesterol, high triglycerides, obesity, or HbA1c ≥ 5.7%) or a diagnosis of diabetes. Before initiating the crossover randomized controlled trial (RCT), the investigators will conduct a preliminary dose-testing study in five adults with at least one metabolic abnormality. Participants will undergo clinical assessments before and after the dietary intervention to evaluate changes in metabolic health markers. Following this phase, the investigators will proceed with a randomized, controlled crossover trial involving 20 eligible adult participants. This main study phase will compare the metabolic effects of daily bottarga supplementation with those of a calorically matched dairy product over an 8-week intervention period, with a 2-week washout period between interventions. The investigators anticipate that bottarga supplementation will improve lipid profiles, inflammation markers, and insulin resistance, thereby supporting the potential use of sustainable blue foods as part of a healthy diet.
Sponsor: Cambridge Health Alliance
Yes, this clinical trial (NCT06988462) has an active research site in Sommerville, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for prediabetes treatment options in Sommerville, MA, this clinical trial (NCT06988462) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sommerville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prediabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all prediabetes clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Sommerville — not just this study.
Browse Essential Tremor Trials in Sommerville →